Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · International Stock · Perpetual Americas

Barrow Hanley International Value Fund (BNIVX)

Ticker BNIVX · Since 2021-12-29 · · Holdings as of Jun 30, 2026

Expense ratio
0.92%$92/yr per $10k
1-yr return
+37.0%as of Dec 2025
Net assets
$14.1Mall share classes
Holdings
62

Bottom line

Is BNIVX a good fund? The bottom line

BNIVX is a managed international stock mutual fund from Perpetual Americas.

Its expense ratio is 0.92% — about $92 a year on every $10,000 invested, more expensive than 52% of international stock funds we track.

It returned +37.0% over one year (as of Dec 31, 2025, per its prospectus).

With $14.1 million in net assets and 62 holdings, its largest position is Toto Ltd (3.2%) and the top 10 make up 24% of the portfolio.

What stands out

  • No front-end sales load

What to watch

  • Small fund ($14.1 million) — small funds are likelier to close

Updated Nov 19, 2026

What BNIVX invests in

The Barrow Hanley International Value Fund (the Fund) seeks to obtain higher returns compared to the MSCI EAFE Value Index.

Under normal circumstances, the Fund invests at least 80% of its net assets, plus any borrowings for investment purposes, in securities of value companies. Additionally, the Fund invests, under normal circumstances, in at least three countries, and invests at least 40% of its total assets in securities of non-U.S. companies. If conditions are not favorable, the Fund will invest at least 30% of its total assets in securities of non-U.S. companies. The Fund considers a company to be a non-U.S. company if: (i) at least 50% of the companys assets are located outside of the U.S.; (ii) at least 50% of the companys revenue is generated outside of the U.S.; (iii) the company is organized or maintains its principal place of business outside of the U.S.; or (iv) the companys securities are traded principally outside of the U.S. The non-U.S. companies in which the Fund invests primarily are…

From the fund's prospectus (filed Jan 28, 2026).

BNIVX performance

Fund calendar-year total returns, 2022–2025 2022: −1.9%; 2023: +16.3%; 2024: −3.3%; 2025: +37.0% −1.9% 2022 +16.3% 2023 −3.3% 2024 +37.0% 2025
Fund gain (+) Fund loss (−)
Average annual total returns
1 yr5 yr10 yr
BNIVX+37.0%——
International Stock median+25.5%+6.4%+7.6%

Source: Fund prospectus, as of Dec 31, 2025

Full BNIVX performance history →

What BNIVX costs

On a $10,000 investment, BNIVX's 0.92% expense ratio costs about $92 a year. The prospectus estimates $1,493 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.

See the full BNIVX fee table →

BNIVX top 10 holdings

#Holding% of fund
1Toto Ltd TOTDF3.17%
2Misumi Group Inc MSUXF2.65%
3Sensata Technologies Holding Plc ST2.50%
4Julius Baer Group Ag JBARF2.41%
5Murata Manufacturing Company Ltd MRAAF2.37%
6Minebea Mitsumi Inc MNBEF2.29%
7Carlsberg A/s CABJF2.23%
8Northern Institutional Funds2.21%
9Bnp Paribas Sa BNPQF2.20%
10Barclays Plc BCLYF2.02%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 24% of the fund. See all top 25 holdings and asset mix →

Alternatives to BNIVX

More funds like BNIVX →

BNIVX FAQ

What is the expense ratio of BNIVX?
BNIVX's expense ratio is 0.92%, which works out to about $92 a year for every $10,000 invested. The prospectus estimates total costs of $1,493 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is BNIVX a good investment?
It depends on your goals, but the data points to: no front-end sales load; small fund ($14.1 million) — small funds are likelier to close. This is general information, not personalized advice.
What does BNIVX hold?
BNIVX's largest holdings are Toto Ltd (3.2%), Misumi Group Inc (2.6%), Sensata Technologies Holding Plc (2.5%), Julius Baer Group Ag (2.4%), Murata Manufacturing Company Ltd (2.4%). It holds 62 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Does BNIVX have a sales load?
No. BNIVX has no front-end sales charge.
Who manages BNIVX?
BNIVX is offered by Perpetual Americas through Perpetual Americas Funds Trust.